A detailed history of Trustcore Financial Services, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Trustcore Financial Services, LLC holds 100 shares of ADPT stock, worth $512. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Previous 100 -0.0%
Holding current value
$512
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Jan 30, 2020

SELL
$24.56 - $32.8 $12,280 - $16,400
-500 Reduced 83.33%
100 $3,000
Q3 2019

Oct 30, 2019

BUY
$30.31 - $53.51 $6,062 - $10,702
200 Added 50.0%
600 $19,000
Q2 2019

Jul 25, 2019

BUY
$40.3 - $48.3 $16,119 - $19,320
400 New
400 $19,000

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $732M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Trustcore Financial Services, LLC Portfolio

Follow Trustcore Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trustcore Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trustcore Financial Services, LLC with notifications on news.